Slingshot Biosciences

Emeryville, CA · Founded 2012 · Privately Held (backing)

Developer of engineered synthetic cells designed to speed up complex drug research. Slingshot Biosciences is based in Emeryville, CA and was founded in 2012. It was valued at $138 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $49.8 million across 2 recorded rounds; the latest was a $26.2 million early-stage round in Jan 2023.

PMV mark · valuation
$138.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$49.8M
Last round
Early Stage VC
Jan 2023
What is Slingshot Biosciences worth?
$138.0MPrivateMarketView mark · Oct 2026

Valued at $138.0M at its later-stage round, Jul 2025. Nothing has traded since.

Free account
More of Slingshot Biosciences with a free account
  • ·Watch Slingshot Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Slingshot Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Jan 2023Early Stage VC$26.2M▮
May 2021Early Stage VC$22.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Slingshot Biosciences valuation

Slingshot Biosciences was valued at $138 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Slingshot Biosciences raised?

Slingshot Biosciences has raised $49.8 million across 2 recorded rounds since 2021. The largest was a $26.2 million early-stage round in Jan 2023.

Slingshot Biosciences has filed 4 Form Ds with the SEC since 2021, most recently in Apr 2024 ($26.2 million sold to 10 investors).

How Slingshot Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Slingshot Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Slingshot Biosciences

What is Slingshot Biosciences worth?
Slingshot Biosciences is valued at $138.0M as of Oct 2026. Valued at $138.0M at its later-stage round, Jul 2025. Nothing has traded since.
How much has Slingshot Biosciences raised?
Slingshot Biosciences has raised $49.8M in total funding across 2 recorded rounds.
When did Slingshot Biosciences last raise?
Slingshot Biosciences last raised in Jan 2023 (Early Stage VC), raising $26.2M.